Electrophysiology stories

FDA approves Johnson & Johnson's dual-energy cardiac ablation catheter combining radiofrequency and pulsed field technology

The FDA has approved J&J's ThermoCool SmartTouch SF Platform, allowing electrophysiologists to switch between radiofrequency and pulsed field energy through a single catheter integrated with the Carto mapping system. U.S. physicians are expected to begin using the device this summer.